Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1957 May;36(5):700–705. doi: 10.1172/JCI103472

IN VIVO STUDIES OF THE ROLE OF ALBUMIN IN ENDOGENOUS AND HEPARIN-ACTIVATED LIPEMIA-CLEARING IN NEPHROTIC RATS 1

Ray H Rosenman 1, Meyer Friedman 1
PMCID: PMC441739  PMID: 13428860

Full text

PDF
700

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALBRINK M. J., GLENN W. W., PETERS J. P., MAN E. B. The transport of lipids in chyle. J Clin Invest. 1955 Sep;34(9):1467–1475. doi: 10.1172/JCI103197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ALBRINK M. J., MAN E. B., PETERS J. P. The relation of neutral fat to lactescence of serum. J Clin Invest. 1955 Feb;34(2):147–157. doi: 10.1172/JCI103069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BRAGDON J. H., HAVEL R. J. In vivo effect of anti-heparin agents on serum lipids and lepoproteins. Am J Physiol. 1954 Apr;177(1):128–133. doi: 10.1152/ajplegacy.1954.177.1.128. [DOI] [PubMed] [Google Scholar]
  4. BYERS S. O., FRIEDMAN M. Role of hyperphospholipidemia and neutral fat increase in plasma in the pathogenesis of hypercholesteremia. Am J Physiol. 1956 Jul;186(1):13–18. doi: 10.1152/ajplegacy.1956.186.1.13. [DOI] [PubMed] [Google Scholar]
  5. BYERS S. O., FRIEDMAN M. The fractionation of cholesterol in body fluids by means of solvent extraction. J Clin Invest. 1956 Apr;35(4):405–410. doi: 10.1172/JCI103291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DRABKIN D. L., MARSH J. B. Metabolic channeling in experimental nephrosis. I. Protein and carbohydrate metabolism. J Biol Chem. 1955 Feb;212(2):623–631. [PubMed] [Google Scholar]
  7. FRIEDMAN M., BYERS S. Role of hyperlipemia in the genesis of hypercholesteremia. Proc Soc Exp Biol Med. 1955 Nov;90(2):496–499. doi: 10.3181/00379727-90-22076. [DOI] [PubMed] [Google Scholar]
  8. GORDON R. S., Jr, BOYLE E., BROWN R. K., CHERKES A., ANFINSEN C. B. Role of serum albumin in lipemia clearing reaction. Proc Soc Exp Biol Med. 1953 Oct;84(1):168–170. doi: 10.3181/00379727-84-20579. [DOI] [PubMed] [Google Scholar]
  9. GORDON R. S., Jr Interaction between oleate and the lipoproteins of human serum. J Clin Invest. 1955 Mar;34(3):477–484. doi: 10.1172/JCI103097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. GROSSMAN M. I., MOELLER H. C., PALM L. Effect of lipemia and heparin on free fatty acid concentration of serum in humans. Proc Soc Exp Biol Med. 1955 Oct;90(1):106–109. doi: 10.3181/00379727-90-21953. [DOI] [PubMed] [Google Scholar]
  11. GROSSMAN M. I., PALM L., BECKER G. H., MOELLER H. C. Effect of lipemia and heparin on free fatty acid content of rat plasma. Proc Soc Exp Biol Med. 1954 Nov;87(2):312–315. doi: 10.3181/00379727-87-21366. [DOI] [PubMed] [Google Scholar]
  12. HERZSTEIN J., WANG C. I., ALDERSBERG D. Effect of heparin on plasma lipid partition in man: studies in normal persons and in patients with coronary atherosclerosis, nephrosis and primary hyperlipemia. Ann Intern Med. 1954 Feb;40(2):290–305. doi: 10.7326/0003-4819-40-2-290. [DOI] [PubMed] [Google Scholar]
  13. HEYMANN W., LUND H. Z. Nephrotic syndrome in rats. Pediatrics. 1951 May;7(5):691–706. [PubMed] [Google Scholar]
  14. KORN E. D. Properties of clearing factor obtained from rat heart acetone powder. Science. 1954 Sep 3;120(3114):399–400. doi: 10.1126/science.120.3114.399-a. [DOI] [PubMed] [Google Scholar]
  15. LEVY S. W., SWANK R. L. The effects of in vivo heparin on plasma esterase activity and lipaemia clearing. J Physiol. 1954 Feb 26;123(2):301–314. doi: 10.1113/jphysiol.1954.sp005052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. MCDANIEL R. A., GROSSMAN M. I. Paper electrophoretic study of C14 fat emulsion cleared from post-heparin rat plasma. Proc Soc Exp Biol Med. 1955 Jul;89(3):442–443. doi: 10.3181/00379727-89-21838. [DOI] [PubMed] [Google Scholar]
  17. PIERCE F. T., Jr The interconversion of serum lipoproteins in vivo. Metabolism. 1954 Mar;3(2):142–153. [PubMed] [Google Scholar]
  18. ROBINSON D. S., FRENCH J. E. The role of albumin in the interaction of chyle and plasma in the rat. Q J Exp Physiol Cogn Med Sci. 1953;38(4):233–239. doi: 10.1113/expphysiol.1953.sp001034. [DOI] [PubMed] [Google Scholar]
  19. ROSENMAN R. H., FRIEDMAN M., BYERS S. O. The causal role of plasma albumin deficiency in experimental nephrotic hyperlipemia and hypercholesteremia. J Clin Invest. 1956 May;35(5):522–532. doi: 10.1172/JCI103305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. ROSENMAN R. H., FRIEDMAN M., BYERS S. O. The distribution of cholesterol and total lipids in the nephrotic rat. J Clin Invest. 1955 May;34(5):700–703. doi: 10.1172/JCI103122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. ROSENMAN R. H., SOLOMON B., BYERS X., FRIEDMAN M. Arresting effect of heparin upon experimental nephrosis in rats. Proc Soc Exp Biol Med. 1954 Jul;86(3):599–603. doi: 10.3181/00379727-86-21176. [DOI] [PubMed] [Google Scholar]
  22. SEIFTER J., BAEDER D. H. Influence of calcium and serum albumin on clearing of lipemic dog plasma in vitro. Proc Soc Exp Biol Med. 1955 Aug;89(4):511–514. doi: 10.3181/00379727-89-21861. [DOI] [PubMed] [Google Scholar]
  23. SEIFTER J., BAEDER D. H. Lipemia clearing by hyaluronidase, hyaluronate, and desoxycorticosterone, and its inhibition by cortisone, stress, and nephrosis. Proc Soc Exp Biol Med. 1954 Aug-Sep;86(4):709–713. doi: 10.3181/00379727-86-21209. [DOI] [PubMed] [Google Scholar]
  24. SPITZER J. J. Removal and mobilization of lipids in normal and hepatectomized dogs. Am J Physiol. 1955 Apr;181(1):83–88. doi: 10.1152/ajplegacy.1955.181.1.83. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES